Company Showcase

How Psilocybin Can Invigorate Your Life

Presented by At this point, it’s likely you’ve heard about the benefits of psilocybin—even if you’ve never tried it. Maybe you’ve read one of the countless recent headlines about its mental and emotional benefits. Maybe one of your friends told you about a psilocybin retreat that transformed their life. And now you’re wondering whether it…

Segal Trials and Psychedelic Research in South Florida

After 24 years… and over 1,200 trials… across more than 75 therapies… Segal Trials is pushing into a new area of expertise—and helping pave the way for psychedelic clinical research. The company was recently selected as the first research site to conduct a Phase 2 study to test the efficacy and safety of LSD as…

Retreats and the Transformative Effects of Ketamine

Presented by What would it look like to create a profound, lasting transformation in your life? To completely rewire your brain to support growth and flexibility? To open yourself up to new awareness and insights you have never considered? To spark creativity and inspiration you have never imagined? Or to address and heal trauma from…

Numinus

Numinus To Follow TSX Upgrade with US Listing in 2022 – CEO

Numinus Wellness [TSX:NUMI], a Vancouver-based psychedelic drug research firm with a network of Canadian ketamine-therapy clinics, plans to follow its December 16 listing on the main Toronto Stock Exchange (TSX) with a listing on a US exchange in 2022, said Numinus CEO and founder, Payton Nyquvest. “We are aiming to list on a major US…